OVERVIEW
The market size for mid-revenue cycle management / clinical documentation improvement is expected to reach USD 4.9 billion by 2024, rising at a CAGR of 7.67% during the forecast period. Market growth is driven largely by the growing use of mid-income cycle management solutions to minimize healthcare costs, track revenue loss due to medical billing and coding errors, handle ever-increasing amounts of unstructured data, and maintain regulatory compliance.
TABLE OF CONTENT
1 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market –Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market –Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market –Â Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market – By Product & Service (Market Size – & million/billion)
8.1 Consulting Services
8.2 Solutions
9 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market – By End-User
9.1 Healthcare Providers
9.1.1 Inpatient Settings
9.1.2 Outpatient Settings
9.2 Healthcare Payers
10 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 3M Company
12.3 Optum, Inc. (A Subsidiary of Unitedhealth Group, Inc.)
12.4 Nuance Communications, Inc.
12.5 Chartwise Medical Systems, Inc.
12.6 Iodine Software
12.7 M*Modal
12.8 Dolbey Systems
12.9 Nthrive, Inc.
12.10 Streamline Health Solutions, LLC
12.11 Vitalware, LLC.
12.12 Company 11 & more
13 Global Mid-Revenue Cycle Management/Clinical Documentation Improvement Market – Appendix
13.1 Sources
13.2 Abbreviations